Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NAUTNAUT
18 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NAUTILUS BIOTECHNOLOGY INC

CITADEL ADVISORS LLC holds 1.9M shares of NAUT (NAUTILUS BIOTECHNOLOGY INC), worth $3.5M as of 2026-Q2. This is a new position. NAUT represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$3.5M

Current Shares

1.9M

Total Value Change

+$3.3M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.9M
-
$3.5M0.0%$1.87
37
2025-Q4
Exited
0
-100.0%
$00.0%$1.91
0
2025-Q3
Increased
254,161
+42.7%
$214,7410.0%$0.80
21
2025-Q2
Increased
178,155
+73.1%
$129,1450.0%$0.69
23
2025-Q1
Decreased
102,928
-53.3%
$88,6210.0%$0.89
0
2024-Q4
Increased
220,220
+177.6%
$369,9700.0%$1.67
38
2024-Q3
Increased
79,339
+28.8%
$226,1160.0%$2.91
20
2024-Q2
Increased
61,578
+10.7%
$144,0930.0%$2.34
17
2024-Q1
Decreased
55,625
-51.6%
$163,5380.0%$2.94
0
2023-Q4
Increased
114,918
+1528.2%
$343,6050.0%$2.99
38
2023-Q3
Increased
7,058
+48.8%
$22,3030.0%$3.16
18
2023-Q2
New
4,742
-
$18,3520.0%$3.47
28
2022-Q4
Exited
0
-100.0%
$00.0%$1.80
0
2022-Q3
Increased
63,062
+82.0%
$134,0000.0%$2.14
23
2022-Q2
Decreased
34,650
-40.7%
$93,0000.0%$2.64
0
2022-Q1
Increased
58,465
+273.9%
$254,0000.0%$4.24
37
2021-Q4
Decreased
15,638
-57.6%
$81,0000.0%$5.35
0
2021-Q3
New
36,892
-
$226,0000.0%$6.16
35

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used